Arcutis Biotherapeutics, Inc. ( ARQT) - Key Metrics
ARQT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.01 | $0.14 | $0.20 | $0.20 |
| 2025Q3 | $0.78 | $0.06 | -$0.01 | -$0.01 |
| 2025Q2 | $0.64 | -$0.13 | $0 | $0 |
| 2025Q1 | $0.52 | -$0.20 | -$0.24 | -$0.25 |
ARQT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 53.53 |
| 2025Q3 | ? | 81.16 |
| 2025Q2 | ? | -28.02 |
| 2025Q1 | ? | -19.66 |
ARQT Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.07% | ? |
| 2025Q4 | 0.70% | ? |
| 2025Q3 | -0.07% | ? |
| 2025Q2 | 0.01% | ? |
| 2025Q1 | -1.57% | ? |
ARQT
Price: $25.61
52 week price:
Earnings Per Share: -0.02 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 827862
Market Capitalization: 2.7 billion